+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Isosilybin B

BP4855
142796-22-3
98%
Phytopurify
Silybum mariamum(L.) Gaertrn.
Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway, it has anti-prostate cancer (PCA) activity that is mediated via cell cycle arrest and apoptosis induction. Isosilybin B showed inhibitory effect on CYP2C8 activity. It inhibited both monophenolase (IC50 = 1.7-7.6 μM) and diphenolase (IC50 = 12.1-44.9 μM) of tyrosinase.
Catalog No Package Original Price Price Inventory Quantity Operating
BP4855-5mg 5mg
BP4855-10mg 10mg
BP4855-20mg 20mg
BP4855-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related diseases

Related targets

TGFB1

Product drug property prediction parameters

  • 155.1400

  • 1.8536

  • 1.7167

  • .2099

  • 1.8028

  • .7023

  • Low

  • 89.0918

  • 3.9920

  • No

  • No

  • No

  • No

  • Yes

  • No

  • 0.0

  • Yes

  • No

  • Yes

  • No